HIVPass: Treating Comorbid Pain and Depression in HIV+ Individuals

Sponsor
Butler Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02766751
Collaborator
(none)
187
4
2
53.5
46.8
0.9

Study Details

Study Description

Brief Summary

This study is designed to look at two different programs that may help people who are HIV+ and have pain and depression. The investigators are trying to understand how to help people learn to live better lives even with these chronic illnesses.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: HIVPASS
  • Behavioral: Health Education
N/A

Detailed Description

The primary aim of this RCT is to evaluate the HIVPass intervention. HIV+ participants (n=236) with chronic pain and depression will be recruited at primary care HIV Clinics through posted advertisements in the waiting rooms of the PCP offices and by physician referral. After an initial phone study screen, research staff will meet with interested individuals in their PCP offices for informed consent, baseline interview and randomization into one of two study groups (Health Education or HIVPass Counseling). Seven intervention sessions (HE or HIVPASS) will occur during the first 3 months of study participation. For all participants, the first session is a collaborative in-person joint session with the participant, his/her PCP and the study BHS. Session 2 is conducted immediately after this collaborative session, and is also in-person. Sessions 3-7 are conducted by phone. Follow-up assessment interviews will be at months 1, 2, 3 (post-intervention), 4, 6, 9 and 12.

Study Design

Study Type:
Interventional
Actual Enrollment :
187 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Treating Comorbid Pain and Depression in HIV+ Individuals
Actual Study Start Date :
Nov 15, 2016
Actual Primary Completion Date :
Jul 1, 2020
Actual Study Completion Date :
May 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Health Education

The seven sessions will cover: 1) nutrition (2 sessions), 2) sleep hygiene, 3) building immunity (e.g., how to avoid colds/flu), 4) injury/disease prevention (e.g., seat belts, sunscreen, when to get regular check-ups/screenings etc.), 5) benefits of exercise/cardiac health, 6) alternative medicine (massage, acupuncture). These sessions will be primarily didactic and consist of health education, followed by discussion as to how this information compares to that which the participants may have been exposed to in the past.

Behavioral: Health Education
The 7-sessions of Health Education is provided to individuals randomized to the Health Education study arm.

Experimental: HIVPASS

Over 7 sessions, the interventionist and the participant will explore the relationship between pain, depressive symptoms, and HIV. General information about pain, HIV and depression will be discussed, as will avoidance of physical activity. Psychoeducation about these areas will be tied to the participant's stated life goals, and exposure exercises and goal lists will be developed. Later sessions will integrate continued efforts towards reaching goals and reducing avoidance. A release of information will be obtained from the participant to allow study session chart notes to be placed in the medical record at the participant's PCP office and to allow the PCP and the study interventionist to discuss treatment coordination.

Behavioral: HIVPASS
The 7-session HIVPASS intervention is provided to individuals randomized to the HIVPASS study arm.

Outcome Measures

Primary Outcome Measures

  1. pain interference [3 months]

    Brief pain inventory, interference scale

Secondary Outcome Measures

  1. depression [3 months; 12 months]

    Quick Inventory of depression symptoms

  2. activity level [3 months; 12 months]

    Assessed with actigraphy

  3. anxiety [3 months; 12 months]

    State-Trait Anxiety Inventory

  4. viral load [3 months, 12 months]

  5. ART adherence [3 months, 12 months]

    AIDS Clinical Trial Group questionnaire

  6. perception of global improvement [3 months, 12 months]

    Patient Global Impression of Change Scale

  7. health related quality of life [3 months, 12 onths]

    Short Form 36 Health Survey

  8. pain interference [12 months]

    brief pain inventory, interference scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Chronic Pain (pain duration for at least six months with a mean score of greater than 3.5 on the BPI Pain Interference Scale)

  • Pain severity > or equal to 4 on a Numeric Rating Scale indicating "average pain in the last week"

  • At least one trial of PCP-recommended medication (i.e. acetaminophen, NSAIDS, muscle relaxants) judged through interviews with patients and PCPs

  • Quick Inventory of Depression Symptoms (QIDS) score of ≥ 9 (depression severity)

  • Stable dose of an antidepressant, if using, for the previous 1 months

  • Age > or equal to 18

  • HIV+

  • Planning to live in the area for the next 6 months

  • Access to a telephone that is typically working.

Exclusion Criteria:
  • In psychotherapy or a multidisciplinary pain management program

  • Planned surgery in the next 6 months

  • Pain thought due to cancer

  • Current mania

  • Past year chronic psychotic condition

  • Excessive substance use (Use of cocaine, heroin, or non-prescribe opioids 15 days per month or more; binge alcohol use 4 days per month or more)

  • Suicidality requiring immediate attention

  • Pregnancy or planned pregnancy in the next 6 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 Boston University/Boston Medical Center Boston Massachusetts United States 02118
2 Hennepin Healthcare Minneapolis Minnesota United States 55415
3 Butler Hospital Providence Rhode Island United States 02906
4 The Miriam Hospital Providence Rhode Island United States 02906

Sponsors and Collaborators

  • Butler Hospital

Investigators

  • Principal Investigator: Michael Stein, MD, Butler Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Michael Stein, MD, Principal Investigator, Butler Hospital
ClinicalTrials.gov Identifier:
NCT02766751
Other Study ID Numbers:
  • 840019
First Posted:
May 10, 2016
Last Update Posted:
Jun 10, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 10, 2021